Advertisement

Outcomes of Lymph Node Dissection for Nonmetastatic Pancreatic Neuroendocrine Tumors: To Dissect or Not To Dissect

  • Jie Hua
  • Si Shi
  • Xianjun YuEmail author
Pancreatic Tumors
  • 13 Downloads

Notes

Disclosures

The authors declare no conflict of interest.

References

  1. 1.
    Mao R, Zhao H, Li K, et al. Outcomes of lymph node dissection for non-metastatic pancreatic neuroendocrine tumors: a propensity score-weighted analysis of the National Cancer Database. Ann Surg Oncol. 2019;26:2722–9.CrossRefGoogle Scholar
  2. 2.
    Kazanjian KK, Reber HA, Hines OJ, et al. Resection of pancreatic neuroendocrine tumors: results of 70 cases. Arch Surg. 2006;141:765–70.CrossRefGoogle Scholar
  3. 3.
    Krampitz GW, Norton JA, Poultsides GA, et al. Lymph nodes and survival in pancreatic neuroendocrine tumors. Arch Surg. 2012;147:820–7.CrossRefGoogle Scholar
  4. 4.
    Jutric Z, Grendar J, Hoen HM, et al. Regional metastatic behavior of nonfunctional pancreatic neuroendocrine tumors: impact of lymph node positivity on survival. Pancreas. 2017;46:898–903.CrossRefGoogle Scholar
  5. 5.
    Hashim YM, Trinkaus KM, Linehan DC, et al. Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs). Ann Surg. 2014;259:197–203.CrossRefGoogle Scholar
  6. 6.
    Zhang XF, Xue F, Dong DH, et al. New nodal staging for primary pancreatic neuroendocrine tumors: a multi-institutional and National Data Analysis. Ann Surg. 2019. http://doi.org/10.1097/SLA.0000000000003478.CrossRefPubMedGoogle Scholar
  7. 7.
    Bosman FT, Carneiro F, Hruban RH, Theise ND. World Health Organization classification of tumours of the digestive system. 4th ed. Lyon: IARC; 2010.Google Scholar

Copyright information

© Society of Surgical Oncology 2019

Authors and Affiliations

  1. 1.Department of Pancreatic SurgeryFudan University Shanghai Cancer CenterShanghaiChina

Personalised recommendations